Novel Honokiol-eluting PLGA-based scaffold effectively restricts the growth of renal cancer cells

Renal Cell Carcinoma (RCC) often becomes resistant to targeted therapies, and in addition, dose-dependent toxicities limit the effectiveness of therapeutic agents. Therefore, identifying novel drug delivery approaches to achieve optimal dosing of therapeutic agents can be beneficial in managing toxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamedani, Yasaman, Chakraborty, Samik, Sabarwal, Akash, Pal, Soumitro, Bhowmick, Sankha, Balan, Murugabaskar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746163/
https://www.ncbi.nlm.nih.gov/pubmed/33332399
http://dx.doi.org/10.1371/journal.pone.0243837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746163/
https://www.ncbi.nlm.nih.gov/pubmed/33332399
http://dx.doi.org/10.1371/journal.pone.0243837

Ejemplares similares